BlackRock, Inc. - 30 Sep 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock (LXEO)

Filing Manager
BlackRock, Inc.
Reporting Manager
BlackRock, Inc.
Symbol
LXEO
Shares outstanding
54,211,100 shares
Disclosed Ownership
2,168,444 shares
Ownership
4%
Form type
SCHEDULE 13G/A
Filing time
17 Oct 2025, 18:13:44 UTC
Date of event
30 Sep 2025
Previous filing
04 Feb 2025
Next filing
21 Jan 2026

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BlackRock, Inc. 4% 2,168,444 2,129,602 0 Spencer Fleming Managing Director